The latest closing stock price for Kiniksa Pharmaceuticals as of November 20, 2024 is 21.21.
An investor who bought $1,000 worth of Kiniksa Pharmaceuticals stock at the IPO in 2018 would have $89 today, roughly 0 times their original investment - a 1.44% compound annual growth rate over 6 years.
The all-time high Kiniksa Pharmaceuticals stock closing price was 30.93 on September 20, 2018.
The Kiniksa Pharmaceuticals 52-week high stock price is 28.15, which is 32.7% above the current share price.
The Kiniksa Pharmaceuticals 52-week low stock price is 15.52, which is 26.8% below the current share price.
The average Kiniksa Pharmaceuticals stock price for the last 52 weeks is 21.05.
An investor who bought $1,000 worth of Kiniksa Pharmaceuticals stock at the IPO in 2018 would have $89 today, roughly 0 times their original investment - a 1.44% compound annual growth rate over 6 years.
The all-time high Kiniksa Pharmaceuticals stock closing price was 30.93 on September 20, 2018.
The Kiniksa Pharmaceuticals 52-week high stock price is 28.15, which is 32.7% above the current share price.
The Kiniksa Pharmaceuticals 52-week low stock price is 15.52, which is 26.8% below the current share price.
The average Kiniksa Pharmaceuticals stock price for the last 52 weeks is 21.05.